VCYT – Veracyte Inc.
VCYT
$25.11Name : Veracyte, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $2,026,263,552.00
EPSttm : 1.54
Veracyte, Inc.
$25.11
VCYT — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
12.07
Margin Of Safety %
80
Put/Call OI Ratio
0.56
EPS Next Q Diff
0.01
EPS Last/This Y
0.17
EPS This/Next Y
-0.22
Price
25.09
Target Price
47.2
Analyst Recom
1.46
Performance Q
-41.06
Upside
-19.8%
Beta
2.03
Ticker: VCYT
22 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-10-13 | VCYT | 43.14 | 0.89 | 0.14 | 6712 |
| 2026-10-14 | VCYT | 43.49 | 0.89 | 2.67 | 6716 |
| 2026-10-15 | VCYT | 44.36 | 0.90 | 0.08 | 6739 |
| 2026-10-16 | VCYT | 43.16 | 0.90 | 207.00 | 6718 |
| 2026-10-19 | VCYT | 43.8 | 0.62 | 0.08 | 5435 |
| 2026-10-20 | VCYT | 44.83 | 0.62 | 3.00 | 5444 |
| 2026-10-21 | VCYT | 46.25 | 0.65 | 0.50 | 5540 |
| 2026-10-22 | VCYT | 46.11 | 0.65 | 7.79 | 5552 |
| 2026-10-23 | VCYT | 47.98 | 0.76 | 0.04 | 5994 |
| 2026-10-26 | VCYT | 48.22 | 0.77 | 0.27 | 5982 |
| 2026-10-27 | VCYT | 50.49 | 0.76 | 0.26 | 5983 |
| 2026-10-28 | VCYT | 50.31 | 0.81 | 0.46 | 5846 |
| 2026-10-29 | VCYT | 52.2 | 0.80 | 0.30 | 5854 |
| 2026-10-30 | VCYT | 49.99 | 0.81 | 0.88 | 5843 |
| 2026-11-02 | VCYT | 49.07 | 0.81 | 0.04 | 5826 |
| 2026-11-03 | VCYT | 50.3 | 0.80 | 1.21 | 5847 |
| 2026-11-04 | VCYT | 52.52 | 0.69 | 1.54 | 5489 |
| 2026-11-05 | VCYT | 23.98 | 0.64 | 0.33 | 6465 |
| 2026-11-06 | VCYT | 24.15 | 0.77 | 1.74 | 6547 |
| 2026-11-09 | VCYT | 25.93 | 0.70 | 0.13 | 6263 |
| 2026-11-10 | VCYT | 24.02 | 0.56 | 0.20 | 6936 |
| 2026-11-11 | VCYT | 25.09 | 0.56 | 0.15 | 6912 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-10-13 | VCYT | 43.12 | -19.5 | -15.2 | 1.91 |
| 2026-10-14 | VCYT | 43.50 | -19.5 | -11.8 | 1.91 |
| 2026-10-15 | VCYT | 44.37 | -19.5 | -9.4 | 1.91 |
| 2026-10-16 | VCYT | 43.16 | -19.5 | -16.0 | 1.91 |
| 2026-10-19 | VCYT | 43.78 | -19.5 | -11.0 | 1.91 |
| 2026-10-20 | VCYT | 43.78 | -19.5 | -11.0 | 1.91 |
| 2026-10-21 | VCYT | 44.81 | -19.5 | -8.1 | 1.91 |
| 2026-10-22 | VCYT | 46.08 | -19.5 | -13.1 | 1.91 |
| 2026-10-23 | VCYT | 47.92 | -19.5 | -8.1 | 1.91 |
| 2026-10-26 | VCYT | 48.24 | -19.5 | -12.0 | 1.91 |
| 2026-10-27 | VCYT | 50.42 | -19.7 | -7.4 | 1.91 |
| 2026-10-28 | VCYT | 50.30 | -19.7 | -7.8 | 1.91 |
| 2026-10-29 | VCYT | 52.17 | -19.7 | -8.5 | 1.91 |
| 2026-10-30 | VCYT | 49.99 | -19.7 | -17.6 | 1.91 |
| 2026-11-02 | VCYT | 49.06 | -19.7 | -14.8 | 1.91 |
| 2026-11-03 | VCYT | 50.29 | -19.7 | -12.1 | 1.91 |
| 2026-11-04 | VCYT | 52.52 | -19.7 | -7.7 | 1.91 |
| 2026-11-05 | VCYT | 23.92 | -19.7 | -75.6 | 1.91 |
| 2026-11-06 | VCYT | 24.00 | -19.7 | 4.0 | 1.91 |
| 2026-11-09 | VCYT | 25.90 | -19.7 | -6.0 | 1.91 |
| 2026-11-10 | VCYT | 24.06 | -24.1 | -23.8 | 1.95 |
| 2026-11-11 | VCYT | 25.09 | -24.7 | -9.6 | 1.95 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
22 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-10-13 | VCYT | -13.90 | 3.56 | 12.90 |
| 2026-10-14 | VCYT | -13.90 | 3.56 | 12.90 |
| 2026-10-15 | VCYT | -13.90 | 3.56 | 12.90 |
| 2026-10-16 | VCYT | -13.90 | 3.56 | 12.90 |
| 2026-10-19 | VCYT | -13.90 | 2.78 | 12.90 |
| 2026-10-20 | VCYT | -13.90 | 2.78 | 12.90 |
| 2026-10-21 | VCYT | -14.00 | 2.78 | 12.90 |
| 2026-10-22 | VCYT | -14.00 | 2.78 | 12.90 |
| 2026-10-23 | VCYT | -14.00 | 2.78 | 12.90 |
| 2026-10-26 | VCYT | -14.00 | 2.80 | 12.90 |
| 2026-10-27 | VCYT | -14.00 | 2.80 | 12.44 |
| 2026-10-28 | VCYT | -14.00 | 2.80 | 12.44 |
| 2026-10-29 | VCYT | -15.47 | 2.80 | 12.44 |
| 2026-10-30 | VCYT | -15.47 | 2.80 | 12.44 |
| 2026-11-02 | VCYT | -15.47 | 3.13 | 12.44 |
| 2026-11-03 | VCYT | -15.47 | 3.13 | 12.44 |
| 2026-11-05 | VCYT | -15.47 | 3.13 | 12.44 |
| 2026-11-06 | VCYT | -15.47 | 3.13 | 12.44 |
| 2026-11-09 | VCYT | -14.93 | 2.97 | 12.40 |
| 2026-11-10 | VCYT | -14.93 | 2.97 | 12.40 |
| 2026-11-11 | VCYT | -14.93 | 2.97 | 12.07 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
21 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
0.38
Avg. EPS Est. Current Quarter
0.4
Avg. EPS Est. Next Quarter
0.39
Insider Transactions
-14.93
Institutional Transactions
2.97
Beta
2.03
Average Sales Estimate Current Quarter
147
Average Sales Estimate Next Quarter
157
Fair Value
45.09
Quality Score
74
Growth Score
66
Sentiment Score
3
Actual DrawDown %
58.8
Max Drawdown 5-Year %
-68.9
Target Price
47.2
P/E
16.2
Forward P/E
15.59
PEG
P/S
3.48
P/B
1.41
P/Free Cash Flow
12.51
EPS
1.55
Average EPS Est. Cur. Y
1.95
EPS Next Y. (Est.)
1.73
Target Price Estimates Raised
Target Price Estimates Lowered
3
Profit Margin
21.8
Relative Volume
1.95
Return on Equity vs Sector %
-17.5
Return on Equity vs Industry %
-2.8
EPS 1 7Days Diff
EPS 1 30Days Diff
0.03
EBIT Estimation
-9.6
◆
VCYT
Healthcare
$25.11
📉
N/A
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
2/20
Pullback
9/25
Volume
0/15
Valuation
20/20
TP/AR
4/10
Options
6/10
RSI
28.7
Range 1M
10.5%
Sup Dist
7.5%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
6/25
Growth
16/30
Estimates
6/20
Inst/Vol
7/15
Options
9/10
EPS Yr
7.8%
EPS NY
-16.1%
52W%
8.3%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+36.3% upside
Quality
8/30
Valuation
18/30
Growth
10/25
Stability
9/10
LT Trend
1/5
Upside
+36.3%
Quality
74
MoS
80%
Click a card to see score breakdown
Full Analysis →
VCYT — P/E HistoricalBiotechnology
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 755
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
VCYT
Latest News
—
Caricamento notizie per VCYT…
stock quote shares VCYT – Veracyte Inc. Stock Price stock today
news today VCYT – Veracyte Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VCYT – Veracyte Inc. yahoo finance google finance
stock history VCYT – Veracyte Inc. invest stock market
stock prices VCYT premarket after hours
ticker VCYT fair value insiders trading